Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 40

1.

Evaluation of Commercially Available Assays for Diagnosis of Acute Dengue in Schoolchildren During an Epidemic Period in Medellin, Colombia.

Piedrahita LD, Agudelo IY, Trujillo AI, Ramírez RE, Osorio JE, Restrepo BN.

Am J Trop Med Hyg. 2016 Aug 3;95(2):315-21. doi: 10.4269/ajtmh.15-0492. Epub 2016 May 16.

PMID:
27185768
2.

No evidence for local adaptation of dengue viruses to mosquito vector populations in Thailand.

Fansiri T, Pongsiri A, Klungthong C, Ponlawat A, Thaisomboonsuk B, Jarman RG, Scott TW, Lambrechts L.

Evol Appl. 2016 Feb 24;9(4):608-18. doi: 10.1111/eva.12360. eCollection 2016 Apr.

3.

Evolutionarily Successful Asian 1 Dengue Virus 2 Lineages Contain One Substitution in Envelope That Increases Sensitivity to Polyclonal Antibody Neutralization.

Wang C, Katzelnick LC, Montoya M, Hue KD, Simmons CP, Harris E.

J Infect Dis. 2016 Mar 15;213(6):975-84. doi: 10.1093/infdis/jiv536. Epub 2015 Nov 17.

PMID:
26582957
4.

Dengue viruses cluster antigenically but not as discrete serotypes.

Katzelnick LC, Fonville JM, Gromowski GD, Bustos Arriaga J, Green A, James SL, Lau L, Montoya M, Wang C, VanBlargan LA, Russell CA, Thu HM, Pierson TC, Buchy P, Aaskov JG, Muñoz-Jordán JL, Vasilakis N, Gibbons RV, Tesh RB, Osterhaus AD, Fouchier RA, Durbin A, Simmons CP, Holmes EC, Harris E, Whitehead SS, Smith DJ.

Science. 2015 Sep 18;349(6254):1338-43. doi: 10.1126/science.aac5017.

5.

Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope.

Robinson LN, Tharakaraman K, Rowley KJ, Costa VV, Chan KR, Wong YH, Ong LC, Tan HC, Koch T, Cain D, Kirloskar R, Viswanathan K, Liew CW, Tissire H, Ramakrishnan B, Myette JR, Babcock GJ, Sasisekharan V, Alonso S, Chen J, Lescar J, Shriver Z, Ooi EE, Sasisekharan R.

Cell. 2015 Jul 30;162(3):493-504. doi: 10.1016/j.cell.2015.06.057. Epub 2015 Jul 16.

6.

The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response.

Flipse J, Smit JM.

PLoS Negl Trop Dis. 2015 Jun 11;9(6):e0003749. doi: 10.1371/journal.pntd.0003749. eCollection 2015. Review.

7.

Modelling the immunological response to a tetravalent dengue vaccine from multiple phase-2 trials in Latin America and South East Asia.

Dorigatti I, Aguas R, Donnelly CA, Guy B, Coudeville L, Jackson N, Saville M, Ferguson NM.

Vaccine. 2015 Jul 17;33(31):3746-51. doi: 10.1016/j.vaccine.2015.05.059. Epub 2015 Jun 4.

8.

Sequential dengue virus infections detected in active and passive surveillance programs in Thailand, 1994-2010.

Bhoomiboonchoo P, Nisalak A, Chansatiporn N, Yoon IK, Kalayanarooj S, Thipayamongkolgul M, Endy T, Rothman AL, Green S, Srikiatkhachorn A, Buddhari D, Mammen MP, Gibbons RV.

BMC Public Health. 2015 Mar 14;15:250. doi: 10.1186/s12889-015-1590-z.

9.

Functionality of dengue virus specific memory T cell responses in individuals who were hospitalized or who had mild or subclinical dengue infection.

Jeewandara C, Adikari TN, Gomes L, Fernando S, Fernando RH, Perera MK, Ariyaratne D, Kamaladasa A, Salimi M, Prathapan S, Ogg GS, Malavige GN.

PLoS Negl Trop Dis. 2015 Apr 13;9(4):e0003673. doi: 10.1371/journal.pntd.0003673. eCollection 2015 Apr.

10.

Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies.

Buddhari D, Aldstadt J, Endy TP, Srikiatkhachorn A, Thaisomboonsuk B, Klungthong C, Nisalak A, Khuntirat B, Jarman RG, Fernandez S, Thomas SJ, Scott TW, Rothman AL, Yoon IK.

PLoS Negl Trop Dis. 2014 Oct 16;8(10):e3230. doi: 10.1371/journal.pntd.0003230. eCollection 2014 Oct.

11.

Utility, limitations, and future of non-human primates for dengue research and vaccine development.

Sariol CA, White LJ.

Front Immunol. 2014 Sep 24;5:452. doi: 10.3389/fimmu.2014.00452. eCollection 2014. Review.

12.

Dengue serotype cross-reactive, anti-e protein antibodies confound specific immune memory for 1 year after infection.

Toh YX, Gan V, Balakrishnan T, Zuest R, Poidinger M, Wilson S, Appanna R, Thein TL, Ong AK, Ng LC, Leo YS, Fink K.

Front Immunol. 2014 Aug 14;5:388. doi: 10.3389/fimmu.2014.00388. eCollection 2014.

13.

Variability in dengue titer estimates from plaque reduction neutralization tests poses a challenge to epidemiological studies and vaccine development.

Salje H, Rodríguez-Barraquer I, Rainwater-Lovett K, Nisalak A, Thaisomboonsuk B, Thomas SJ, Fernandez S, Jarman RG, Yoon IK, Cummings DA.

PLoS Negl Trop Dis. 2014 Jun 26;8(6):e2952. doi: 10.1371/journal.pntd.0002952. eCollection 2014 Jun.

14.

Induction of neutralizing antibody response against four dengue viruses in mice by intramuscular electroporation of tetravalent DNA vaccines.

Prompetchara E, Ketloy C, Keelapang P, Sittisombut N, Ruxrungtham K.

PLoS One. 2014 Jun 2;9(6):e92643. doi: 10.1371/journal.pone.0092643. eCollection 2014.

15.

Time-varying, serotype-specific force of infection of dengue virus.

Reiner RC Jr, Stoddard ST, Forshey BM, King AA, Ellis AM, Lloyd AL, Long KC, Rocha C, Vilcarromero S, Astete H, Bazan I, Lenhart A, Vazquez-Prokopec GM, Paz-Soldan VA, McCall PJ, Kitron U, Elder JP, Halsey ES, Morrison AC, Kochel TJ, Scott TW.

Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):E2694-702. doi: 10.1073/pnas.1314933111. Epub 2014 May 20.

16.

Human immune responses to dengue virus infection: lessons learned from prospective cohort studies.

Endy TP.

Front Immunol. 2014 Apr 24;5:183. doi: 10.3389/fimmu.2014.00183. eCollection 2014. Review.

17.

Differential susceptibility of two field aedes aegypti populations to a low infectious dose of dengue virus.

Pongsiri A, Ponlawat A, Thaisomboonsuk B, Jarman RG, Scott TW, Lambrechts L.

PLoS One. 2014 Mar 24;9(3):e92971. doi: 10.1371/journal.pone.0092971. eCollection 2014.

18.

Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand.

Sirivichayakul C, Sabchareon A, Limkittikul K, Yoksan S.

Virol J. 2014 Mar 12;11:48. doi: 10.1186/1743-422X-11-48.

19.

Detection of serotype-specific antibodies to the four dengue viruses using an immune complex binding (ICB) ELISA.

Emmerich P, Mika A, Schmitz H.

PLoS Negl Trop Dis. 2013 Dec 26;7(12):e2580. doi: 10.1371/journal.pntd.0002580. eCollection 2013.

20.

Symptomatic versus inapparent outcome in repeat dengue virus infections is influenced by the time interval between infections and study year.

Montoya M, Gresh L, Mercado JC, Williams KL, Vargas MJ, Gutierrez G, Kuan G, Gordon A, Balmaseda A, Harris E.

PLoS Negl Trop Dis. 2013 Aug 8;7(8):e2357. doi: 10.1371/journal.pntd.0002357. eCollection 2013.

Items per page

Supplemental Content

Write to the Help Desk